WRIGHT EVOLVE EPS ORTHOLOC System Cleaning and Handling Instructions

EN

Attention Operating Surgeon

IMPORTANT MEDICAL INFORMATION WRIGHT MEDICAL EVOLVE® EPS ORTHOLOC™ SYSTEM (150858-0) OUTLINE: I. GENERAL PRODUCT INFORMATION A. PATIENT SELECTION B. CONTRAINDICATIONS C. POTENTIAL COMPLICATIONS AND ADVERSE REACTIONS D. PRECAUTIONS E. HANDLING AND STERILIZATION F. STORAGE CONDITIONS II. EVOLVE® EPS ORTHOLOC™ A. EVOLVE® EPS ORTHOLOC™ SYSTEM DEFINITIONS Symbols and abbreviations may be used on the package label. The following table provides the definition of these symbols and abbreviations.

3

Table 1. Definitions of Symbols and Abbreviations Symbol

Definition

g h

Batch code

D Y i H l p

Do not re-use

Catalog number Caution, consult accompanying documents Consult operating instructions Use by Temperature limitation Keep dry Keep away from sunlight

N M P[] I

Date of manufacture Manufacturer Authorized EC Representative in the European Community Sterilized using ethylene oxide

4

K STERILE GAS

J

Sterilized using radiation Sterilized using gas plasma Sterilized using aseptic processing techniques For prescription use only

Abbreviation Ti

Titanium

Ti6Al4V

Titanium Alloy

CoCr

Cobalt Chrome Alloy

SS UHMWPE I.

Material

Stainless Steel Ultra High Molecular Weight Polyethylene

GENERAL PRODUCT INFORMATION Through the advancement of surgical fusion hardware, the surgeon has been provided a means of correcting deformity and reducing pain for many patients. While the implants used are largely successful in attaining these goals, it must be recognized that they are manufactured from metal, and that no implant can be expected to withstand the activity levels and loads as would normal, healthy bone after fusion occurs.

5

Each patient must be evaluated by the surgeon to determine the risk/benefit relationship. In using fusion implants, the surgeon should be aware of the following: • The correct selection and sizing of the implant is extremely important. Selection of the proper size, shape, and design of the implant increases the potential for success. The implants require careful seating and adequate bone support. • In selecting patients for surgery, the following factors can be critical to the eventual success of the procedure: 1. Patient’s occupation or activity. If the patient is involved in an occupation or activity which includes substantial lifting or muscle strain, the resultant forces can cause failure of the fixation, the device, or both. The implant will not restore function to the level expected with normal healthy bone, and the patient should not have unrealistic functional expectations. 2. Condition of senility, mental illness, or alcoholism. These conditions, among others, may cause the patient to ignore certain necessary limitations and precautions in the use of the implant, leading to failure or other complications. 3. Foreign body sensitivity. Where material sensitivity is suspected, appropriate tests should be made prior to material selection or implantation. A. PATIENT SELECTION Use of surgical fusion hardware requires consideration of the following general indications: • Good condition of the patient • Good neurovascular status • Adequate skin coverage

6

• • • •

Possibility of a functional musculotendinous system Adequate bone stock to receive implant Availability of post-operative therapy Cooperative patient

See Section II for specific product information. B. CONTRAINDICATIONS • Infection • Physiologically or psychologically inadequate patient • Inadequate skin, bone, or neurovascular status • Irreparable tendon system • Possibility for conservative treatment • Growing patients with open epiphyses • Patients with high levels of activity C. POTENTIAL COMPLICATIONS AND ADVERSE REACTIONS In any surgical procedure, the potential for complications exists. The risks and complications with these implants include: • Infection or painful, swollen or inflamed implant site • Fracture of the implant • Loosening or dislocation of the implant requiring revision surgery

7

• • • • •

Bone resorption or over-production Allergic reaction(s) to implant material(s) Untoward histological responses possibly involving macrophages and/or fibroblasts Migration of particle wear debris possibly resulting in a bodily response Embolism

See Section II for specific product information. D. PRECAUTIONS Following the instructions for use provided in product literature can minimize the potential for complications or adverse reactions with any implant. It is the responsibility of each surgeon using implants to consider the clinical and medical status of each patient and to be knowledgeable about all aspects of implant procedure and the potential complications that may occur. The benefits derived from implant surgery may not meet the patient’s expectations or may deteriorate with time, necessitating revision surgery to replace the implant or to carry out alternative procedures. Revision surgeries with implants are common. The patient’s mental status must also be considered. Willingness and/or ability to follow post-operative instructions may also impact the surgical outcome. Surgeons must balance many considerations to achieve the best result in individual patients. IF EXCESSIVE LOADING CANNOT BE PREVENTED, AN IMPLANT SHOULD NOT BE USED.

8

The main goal of surgery with this implant is to establish bony fusion. Abnormal or excessive forces could lead to delayed union, non-union, or failure of the implant. Abnormal force loading and subsequent wear may be caused by: • Uncorrected instability • Improperly sized implant • Inadequate soft tissue support • Implant malposition • Excessive motion • Uncorrected or recurrent deformity • Patient misuse or overactivity Proper fixation at the time of surgery is critical to the success of the procedure. Bone stock must be adequate to support the device. Some preventative measures to consider to minimize the potential for complications: • Follow guidelines for indications and contraindications provided above • Identify prior pathology • Stabilize collapse deformities • Bone graft pre-existing cysts • Use a properly sized implant • Avoid K-wires and sutures through the implant

9

Avoid flawing implant surfaces to minimize the potential for early fatigue failure. If complications develop, possible corrective procedures include: • Implant removal • Synovectomy • Bone grafting of cysts • Replacement of the implant • Removal of the implant with fusion of the joint Over time, metallic implants may loosen, fracture, or cause pain after the bone fracture or osteotomy is healed. Removal of metallic implants is at the surgeon’s discretion, and the appropriateness of the selected procedure will be based on the surgeon’s personal medical training and experience. It is imperative that adequate post-operative care and protection be provided by the surgeon. Recommendations Regarding Device Fragments 1. Use medical devices in accordance with their labeled indications and the manufacturer’s instructions for use, especially during insertion and removal. 2. Inspect devices prior to use for damage during shipment or storage or any out-of-box defects that might increase the likelihood of fragmentation during a procedure. 3. Inspect devices immediately upon removal from the patient for any signs of breakage or fragmentation. 4. If the device is damaged, retain it to assist with the manufacturer’s analysis of the event.

10

5. Carefully consider and discuss with the patient (if possible) the risks and benefits of retrieving vs. leaving the fragment in the patient. 6. Advise the patient of the nature and safety of unretrieved device fragments including the following information: a. The material composition of the fragment (if known); b. The size of the fragment (if known); c. The location of the fragment; d. The potential mechanisms for injury, e.g., migration, infection; e. Procedures or treatments that should be avoided such as MRI exams in the case of metallic fragments. This may help to reduce the possibility of a serious injury from the fragment. Clinical results depend on surgeon and technique, pre-operative and post-operative care, the implant, patient pathology and daily activity. It is important that surgeons obtain appropriate informed consent and discuss the potential for complications with each patient prior to surgery. This may include a review of alternative, non-implant procedures such as soft tissue reconstruction or arthrodesis. Concerning Magnetic Resonance Environments The devices described in this package insert have not been evaluated for safety and compatibility in the MR environment. The devices described in this package insert have not been tested for heating or migration in the MR environment. See Section II for specific product information.

11

E. HANDLING AND STERILIZATION IMPLANTS The implants in this system are either provided sterile or non-sterile; the individual product’s labeling will determine whether or not it is packaged sterile. Implants that are presented in instrument trays are provided non-sterile. Implants in sterile packaging should be inspected to ensure that the packaging has not been damaged or previously opened. If the inner package integrity has been compromised, contact the manufacturer for further instructions. The implants should be opened using aseptic OR technique; they should only be opened after the correct size has been determined. Implants provided non-sterile should be processed according to the recommended parameters for instruments (below). This product is for single use only. An implant should never be re-sterilized after contact with body tissues or fluids. Devices labeled for single-use only should never be reused. Reuse of these devices may potentially result in, but are not limited to, significant degradation in device performance, cross-infection, or contamination which may result in serious patient harm. INSTRUMENTS Surgical instruments (and non-sterile implants) should be cleaned and sterilized according to the following parameters:

12

Cleaning 1. Disassemble as per manufacturer instructions (if appropriate). 2. Rinse with cold tap water to remove gross contamination. 3. Bathe in an enzymatic detergent solution prepared per manufacturer directions for 5 minutes. 4. Scrub thoroughly with a soft brush and/or pipe cleaner; repeatedly flush any very narrow lumens with enzymatic detergent solution using a syringe. 5. Rinse with cold tap water for a minimum of one minute; use a syringe to repeatedly flush any very narrow lumens. 6. Bathe in a detergent solution prepared per manufacturer directions for 5 minutes. 7. Scrub thoroughly with a soft brush and/or pipe cleaner; repeatedly flush any very narrow lumens with detergent solution using a syringe. 8. Rinse thoroughly /flush with deionized / reverse osmosis (RO/DI) water. 9. Sonicate for a minimum of 10 minutes in an enzymatic detergent solution prepared per manufacturer directions. 10. Rinse thoroughly /flush with RO/DI water. 11. Dry with a clean, soft, absorbent, disposable cloth. 12. Visually inspect for cleanliness. All visible surfaces, internal and external, should be visually inspected. If necessary re-clean until it is visibly clean. Note: Brushes (i.e. pipe cleaners) could be used for cleaning most lumens, however, the use of a syringe to flush narrow lumens with diameters less than or equal to 0.041 inches is recommended.

13

Sterilization 1. Double wrap the component in an FDA-cleared CSR wrap or a similar type nonwoven medical grade wrapping material. 2. Autoclave according to the following parameters: Steam Sterilization Cycle Type Prevacuum 270°F (132°C)

Parameter

Minimum Set Point

Exposure Temperature

270°F (132°C)

Exposure Time

4 minutes

Dry Time

20 minutes

3. After sterilization, remove the component from its wrapping using accepted sterile technique with powder-free gloves. Ensure that implants are at room temperature prior to implantation. Avoid contact with hard objects that may cause damage. These recommendations are consistent with AAMI ST79:2006/A1:2008 & A2:2009 and have been developed and tested using specific equipment. Due to variations in environment and equipment, it must be demonstrated that these recommendations produce sterility in your environment. If processing conditions, wrapping materials, or equipment changes occur, the effectiveness of the sterilization process must be demonstrated.

14

For additional information see WMT’s Cleaning and Handling of Wright Medical Instruments. F. STORAGE CONDITIONS All implants must be stored in a clean, dry environment and be protected from sunlight and extremes in temperature. II. SPECIFIC PRODUCT INFORMATION A. EVOLVE® EPS ORTHOLOC™ SYSTEM DESCRIPTION The EVOLVE® EPS ORTHOLOC™ System consists of a variety of pre-contoured plate geometries. The plates feature compression slots and locking screw holes. The associated screws are available in a range of lengths. All components are manufactured from stainless steel. INDICATIONS The EVOLVE® EPS ORTHOLOC™ System is intended for fixation of fractures, osteotomies and non-unions of the olecranon, humerus, radius and ulna.

15

CONTRAINDICATIONS The EVOLVE® EPS ORTHOLOC™ System is contraindicated for the following: • In patients with probable history of infection or current infection • Overt infection • Skeletally immature patients Trademarks™ and Registered Trademarks® are owned or licensed by Wright Medical Technology, Inc.

16